Thank you, Charlie, and thank you, everyone, for joining our call today. I'm delighted to communicate to you that at Enovix, we are executing really well, and it's been a solid quarter. We did hit a lot of key milestones this quarter. Firstly, we produced 12,500 batteries in our Fab-1 here in Fremont. This is ahead of our forecast of 9,000 batteries that we talked about last time. Now we also completed a rigorous design approval of our Gen2 Autoline, and we did this ahead of schedule. We completed the purchase orders for both the high-volume Gen2 Autoline, and also the agility line, which we will use for sampling our customers for qualifying their products. Now we also chose a site in Malaysia for our fab two, and we did this also ahead of schedule. Now I'm super excited also to tell you that we hired a leadership team there and 25 engineers already and we see a path for non-dilutive financing of our first production line. Now I'll expand on that in a moment, as we go through the presentation. Then after the quarter, we closed $172.5 million convertible debenture, which is intended to fund our Gen2, 3 & 4 autolines. We did at a very minimum dilution to our shareholders, super excited by that offering that we closed. Lastly, this quarter, we made a number of leadership additions very excited by some really strong people that joined our teams from our previous associations. And now I believe we are totally set up to scale. Now we are already seeing the impact of the people that we have hired with strong progress in all our R&D programs and also in the manufacturing that we are making. Now format-wise, I really wanted to cover two topics today. And then, we'll hop into Q&A and answer any questions you have. Firstly, in the last three months that I've been here, I received most number of questions about two things, and I'm going to get those. The first question was that I've received many times is, why do we believe that our Gen2 line will be successful and we'll be able to produce millions of batteries and do high-volume manufacturing, given that we had some early missteps of our Gen1 production line. So I'm going to talk about that now. Now, I've been here a little over three months, and Ajay has been here about five. And I can tell you both Ajay and I have tremendous experience for many, many decades in semiconductor industry. And drawing from that, we've come to the conclusion after looking at Enovix manufacturing process, that these can absolutely scale. And actually, they have some inherent advantages even to making chips. And I'll tell you why here in a few minutes. Now, in semiconductors, if you look at manufacturing chips, really there are two processes, there's a front-end process and the backend process. The front-end process is where you make the wafer fabrication, which is a very complicated process where we use very expensive machines to make the wafers. Then there's the backend process, which is basically assembly and test. Here, you take the dies and cut into small pieces, the small dies, and then you put them in a package. The front-end is in a deep sub-micron manufacturing, and the backend process is actually a lot more forgiving. Here, the mechanical tolerances to which we have to do are actually in single-digit microns. Now, if you apply that analogy of semiconductor manufacturing to how Enovix makes batteries, the front-end process of the semiconductor manufacturing is very similar to the materials that go into the battery, these are the anodes and the cathodes, and the electrolytes and so on. Now, we at Enovix, don't manufacture those, we actually buy them from the best suppliers in the world. They come in big rolls of coated electrodes. What we do then is we laser pattern them, we stack them, apply mechanical constraint, and that is really similar to the backend process in semiconductors. Now there's one big difference, the tolerances to which we have to make these batteries, the tolerances to which we have to design our machines and execute this manufacturing is in the 50 microns range. As I mentioned, in backend semiconductors, typically, it is in the 5-microns range. So that's kind of a long way of saying it's an order of magnitude simpler problem in mechanical tolerancing. This is why Ajay and I believe is absolutely, we'll be able to do this, and we'll be able to manufacture at scale. Now, the proof of that is what you're seeing in the operational improvements that you're seeing from us. You can see how we're executing on Fab-1 and continue to produce 1,000s of batteries. And we're also hitting all the key milestones on getting the Gen2 up and running. Now Gen2 compared to Gen1 is really all about adding speed, adding speed and automation and parallelism, so that we can handle more tasks at once. To give you all a feel for what Gen2 looks like compared to Gen1, we made a short video where Ajay describes how this works. And there's a link to the video in the shareholder letter that you received. And it shows you Ajay presenting side-by-side how these work of Gen1 and Gen2 machines. I encourage all of you to please click on that and take a look at that. It's a short video, but it does really illustrate the point that I'm trying to make here. Now, what is this advantage that Enovix batteries have compared to semiconductors? One of the aha moments for me in the last quarter since I've been here at Enovix is realizing that we can produce higher density and much better capacity batteries with the longer cycle life without having to change our manufacturing process. This is actually very important to understand. Now in my experience in semiconductors, let's say you wanted to make a higher-performance processor or a high-density memory, you pretty much most of the time have to buy brand-new machines and go from one process node to the other. And again, these are deep sub-micron lithography machines that cost hundreds of millions of dollars. And sometimes the fab has to be kind of upgraded and rebuilt to really house these machines. What we find at Enovix is that the manufacturing lines we are building since they're akin to the backend manufacturer, as we make advances in getting better electrodes, better cathodes, better silicon-based anodes, better electrolytes, which we have, our electro chemists are working on sourcing them and making experiments with them. We can use the exact same machines that we are building to make those batteries. In other words, as we make advances in electrochemistry, and we make advances in higher energy density, our manufacturing footprint totally scales. It's not like we have to build completely new batteries in new manufacturing facilities every time you wanted to improve energy density. This is a fundamentally a huge advantage for the way we manufacture batteries. So that is what I believe will make this business ultimately very profitable in the long run. Now, the second major topic I wanted to talk to you about is the capacity build-out. Now that we've gotten a lot of questions on this, as I talk to investors over the last quarter. I mentioned last time that we will have multiple options to raise money or build - get the financing we need to build our capacity. Now we are now executing towards that. This quarter, we got a non-binding LOI or a letter of intent from our manufacturing partner, YBS International, in Malaysia. This LOI has YBS working on giving us an existing building space in Penang Science Park to house our high-volume manufacturing lines up to four lines with dedicated personnel to staff that line. This is very similar to how we would use a semiconductor backend assembly subcontractor. Now, YBS, in addition to this, is working with a syndicate of local banks to make a significant investment in our Gen2 autoline. This is subject to some purchase commitment from Enovix. Now, while we are negotiating all the details, what I can share with you is that we are seeking at least 70 plus million dollars of non-dilutive financing to fund the first line. Now, as I said earlier, this funding is not secured yet. But we are very encouraged by all the discussions we have to date with them. Securing this funding, now would elevate us from spending the $120 million full year CapEx forecast I gave you last time. Now we'll provide an update for you on this in the next quarterly call. Now beyond that funding, we recently closed the private offering of the $172.5 million convertible senior notes. That gives us the CapEx, the capital we need to make the Gen2 autolines 2, 3 & 4. So in other words, we are now set up to be able to build four auto lines in Malaysia in terms of CapEx that we need. Now, let me close with our outlook, with a few remarks here. For the full year of 2023, we continue to expect to produce the 180,000 cells that I mentioned last time, including 18,000 cells in second quarter. Now once again, we're not forecasting any service revenue at this point, because this tends to be episodic and based on milestones. Now, I want to reiterate our full cash guidance of $240 million of spend half from CapEx and half from operationally running the company. We do plan to revise this guidance in the next quarterly call as we get more visibility on the YBS transaction, in addition to our own efforts to internally operate a lot more efficiently. In closing, we're off to a fast start. We're making substantial improvements in Fab-1, we're hitting all the milestones we set for ourselves and that I communicated last time to you, our journey to scale in Fab-2 in Malaysia. We are working to fund our capacity build outs while protecting our cash and limiting our dilution. Now I really want to thank all the Enovix employees for their hard work this quarter, along with the investors who actually are supporting us in our efforts. Now we have a busy year in front of us. But I'm even more confident today than I was when I joined that we have the right product and the right team to achieve our goals and enhance the shareholder value. With that, I will turn it to Q&A.